Florida Senate - 2017                                    SB 1002
       
       
        
       By Senator Perry
       
       
       
       
       
       8-01311-17                                            20171002__
    1                        A bill to be entitled                      
    2         An act relating to controlled substances; amending s.
    3         893.03, F.S.; adding ioflupane as an excepted
    4         substance to Schedule II of the standards and
    5         schedules of controlled substances; providing an
    6         effective date.
    7          
    8  Be It Enacted by the Legislature of the State of Florida:
    9  
   10         Section 1. Paragraph (a) of subsection (2) of section
   11  893.03, Florida Statutes, is amended to read:
   12         893.03 Standards and schedules.—The substances enumerated
   13  in this section are controlled by this chapter. The controlled
   14  substances listed or to be listed in Schedules I, II, III, IV,
   15  and V are included by whatever official, common, usual,
   16  chemical, trade name, or class designated. The provisions of
   17  this section shall not be construed to include within any of the
   18  schedules contained in this section any excluded drugs listed
   19  within the purview of 21 C.F.R. s. 1308.22, styled “Excluded
   20  Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical
   21  Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted
   22  Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt
   23  Anabolic Steroid Products.”
   24         (2) SCHEDULE II.—A substance in Schedule II has a high
   25  potential for abuse and has a currently accepted but severely
   26  restricted medical use in treatment in the United States, and
   27  abuse of the substance may lead to severe psychological or
   28  physical dependence. The following substances are controlled in
   29  Schedule II:
   30         (a) Unless specifically excepted or unless listed in
   31  another schedule, any of the following substances, whether
   32  produced directly or indirectly by extraction from substances of
   33  vegetable origin or independently by means of chemical
   34  synthesis:
   35         1. Opium and any salt, compound, derivative, or preparation
   36  of opium, except nalmefene or isoquinoline alkaloids of opium,
   37  including, but not limited to the following:
   38         a. Raw opium.
   39         b. Opium extracts.
   40         c. Opium fluid extracts.
   41         d. Powdered opium.
   42         e. Granulated opium.
   43         f. Tincture of opium.
   44         g. Codeine.
   45         h. Ethylmorphine.
   46         i. Etorphine hydrochloride.
   47         j. Hydrocodone.
   48         k. Hydromorphone.
   49         l. Levo-alphacetylmethadol (also known as levo-alpha
   50  acetylmethadol, levomethadyl acetate, or LAAM).
   51         m. Metopon (methyldihydromorphinone).
   52         n. Morphine.
   53         o. Oxycodone.
   54         p. Oxymorphone.
   55         q. Thebaine.
   56         2. Any salt, compound, derivative, or preparation of a
   57  substance which is chemically equivalent to or identical with
   58  any of the substances referred to in subparagraph 1., except
   59  that these substances may shall not include the isoquinoline
   60  alkaloids of opium.
   61         3. Any part of the plant of the species Papaver somniferum,
   62  L.
   63         4. Cocaine or ecgonine, including any of their
   64  stereoisomers, and any salt, compound, derivative, or
   65  preparation of cocaine or ecgonine, except that these substances
   66  may not include ioflupane (123I).
   67         Section 2. This act shall take effect July 1, 2017.